Pfizer Hit With Class-Action Lawsuit Alleging Deceptive Marketing of Lipitor

Drug Industry Daily
KEYWORDS Advertising / courts
A A

Pfizer’s promotional strategy for Lipitor, the world’s top-selling drug, targeted patient populations that had not been covered in clinical trials of the cholesterol-lowering treatment, resulting in billions of dollars in unnecessary drug spending, alleges a class-action lawsuit filed by consumer groups.

To View This Article:

Login

Subscribe To Drug Industry Daily